InvestorsHub Logo
Followers 7
Posts 1303
Boards Moderated 0
Alias Born 03/08/2019

Re: None

Thursday, 05/09/2019 5:12:00 PM

Thursday, May 09, 2019 5:12:00 PM

Post# of 44095
If the new CEO really is changing the business focus to tissue culture genetics then it's a smart move in my opinion. If they truly have the expertise to mass produce high THC clones from tissue culture it's a game changer for the company.

Massachusetts growers will need millions of clones for the new recreational market. If the company can produce a good hardy strain of high yield cannabis they are sitting pretty in a huge market.

That's a lot of if's, but the CEO has experience in this field, and sounds optimistic about the future. Maybe all this recent volume is related to a merger of the CEO's cannabis cloning research company, and Indoor Harvest. Volume out of nowhere feels like big news to me. imho glta

Indoor Harvest Corp Lays Out Growth Plans for its Proprietary Aeroponic Technology -- Spotlight Growth

https://www.globenewswire.com/news-release/2019/01/31/1708325/0/en/Indoor-Harvest-Corp-Lays-Out-Growth-Plans-for-its-Proprietary-Aeroponic-Technology-Spotlight-Growth.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INQD News